CONCORDBIO

HealthcareBiotechnologyMid Cap
Concord Biotech Limited

Concord Biotech Limited is a biopharma company operating in the Healthcare sector, specifically Biotechnology. It conducts research, development, manufacturing, marketing, and sale...

हिन्दी में

Concord Biotech Limited एक बायोफार्मा कंपनी है जो हेल्थकेयर सेक्टर, विशेष रूप से बायोटेक्नोलॉजी में काम करती है। यह भारत और अंतरराष्ट्रीय स्तर पर फार्मास्युटिकल उत्पादों का अनुसंधा...

₹1,361.4+2.30%1D
Previous trading day close · Data updates after market close
1W: +0.4%
1M: -7.0%
6M: +30.1%
1Y: -16.3%
56/100
AverageResearch Score
Market Cap
₹13.4K Cr
Mid Cap
P/E Ratio
46.90
Premium
P/B Ratio
7.06
Premium
ROE
22.3%
Strong
ROCE
16.7%
Good
Debt / Equity
0.00
Low debt
Div. Yield
0.6%
Low yield
EV/EBITDA
33.52
Expensive
52W Low: ₹987Current: ₹1,361.452W High: ₹1,647.8
At 57% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
74/100
Growth
Revenue, EPS, profit growth
46/100
Valuation
PE, PB, EV/EBITDA vs sector
19/100
Risk
Debt levels, volatility, coverage
89/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
46.90(Premium)
Forward P/E
32.00(Premium)
P/B Ratio
7.06(Premium)
P/S Ratio
12.85(Expensive)
EV/EBITDA
33.52(Expensive)
Dividend Yield
0.6%
5Y CAGR
N/A
Revenue Growth
26.2%(High)
Profitability
ROE
22.3%(Excellent)
ROCE
16.7%(Good)
ROA
19.9%(Efficient)
Net Margin
24.8%(High)
EBITDA Margin
40.1%
Financial Health
Debt to Equity
0.00(Low debt)
Current Ratio
6.17(Healthy)
Quick Ratio
4.87(Good)
Interest Coverage
1223.15x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
36(Neutral)
RSI Exp (14)
29(Oversold)
MACD
-30.844(Bearish)
MACD Signal
-17.107
BB Position
24%(Middle)
BB Width
20.35%(High volatility)
ADX (14)
29.1(Strong trend)
Williams %R
-81.6(Oversold)
MFI (14)
49(Neutral)
CCI (20)
-98(Neutral)
Stoch %K
18(Oversold)
ATR (14)
57.34(Avg True Range)
OBV (M)
40.4(Positive)
1W OBV Chg
-0.3%(Decreasing)
Rel Volume
0.81x(Normal)
Volatility
43.1%(High)
Max DD 1Y
-56.7%(High loss)
Alpha (CAPM)
-16.64%(Underperforming)
Return vs Nifty
-5.9%(Below Nifty)
EMA 200
1366.1
EMA 50
1418.5
SMA 200
1269.2
vs SMA 50
-6.4%(Below SMA50)
vs SMA 200
7.3%(Above SMA200)
Volume
1.28L
Avg Vol 3M
1.6L
Shareholding Pattern
Promoter
44.1%
Moderate
FII
7.8%
DII / MF
9.2%
Share CONCORDBIO
Share this stock analysis with your network
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.